Results 71 to 80 of about 1,546,198 (186)
Cystic fibrosis year in review 2023
Abstract This past year, there were many important advances for patients with cystic fibrosis (CF). Of the many publications related to CF in 2023, there was further evaluation of highly effective modulator therapy, new assessments and guidelines for clinical manifestations and therapies for CF, advances in newborn screening and diagnosis, and ...
David V. Swetland, Adrienne P. Savant
wiley +1 more source
Objective: To examine the global burden, associated point sources, and successful prevention and control measures for documented outbreaks of Burkholderia cepacia healthcare-associated infections (HAIs). Design: Integrative review.
Russo, Philip L +16 more
core +1 more source
Burkholderia cenocepacia is an opportunistic pathogen particularly dangerous for cystic fibrosis (CF) patients. It can cause a severe decline in CF lung function possibly developing into a life-threatening systemic infection known as cepacia syndrome ...
Viola C. Scoffone +6 more
doaj +1 more source
Cefiderocol utilization in lung transplant recipients at a single center
A retrospective analysis of cefiderocol utilization in lung transplant recipients at a single center. This study highlights the primary indications, adverse effects, and mortality outcomes, among other measures, providing insight into its potential use in managing multidrug‐resistant infections in this population.
Purnadeo N. Persaud +4 more
wiley +1 more source
Surviving but stigmatised:Making sense of living with Burkholderia cepacia
Infection control policies recommend segregation of people with Cystic Fibrosis (CF) according to bacterial status. This involves isolating those people with cepacia from all other CF patients in order to prevent additional infection.
Smallman, Elaine +2 more
core +2 more sources
Abstract The qualified presumption of safety (QPS) process was developed to provide a safety assessment approach for microorganisms intended for use in food or feed chains. In the period covered by this statement, no new information was found that would change the status of previously recommended QPS TUs. The TUs in the QPS list were updated based on a
EFSA Panel on Biological Hazards (BIOHAZ) +27 more
wiley +1 more source
ТРАНСПЛАНТАЦИЯ ЛЕГКИХ ПРИ МУКОВИСЦИДОЗЕ С ХРОНИЧЕСКИМ ИНФИЦИРОВАНИЕМ ДЫХАТЕЛЬНЫХ ПУТЕЙ BURKHOLDERIA CEPACIA (первое наблюдение в Российской Федерации) [PDF]
Cystic fibrosis (CF) is the third most common indication for lung transplantation. The recipients with CF have shown the best early and late survival rates after surgery.
M. M. Vodneva +19 more
core +1 more source
Background Burkholderia cenocepacia, an opportunistic pathogen that causes lung infections in cystic fibrosis (CF) patients, is associated with rapid and usually fatal lung deterioration due to necrotizing pneumonia and sepsis, a condition known as ...
Saliba Alessandra M +7 more
doaj +1 more source
91 Retrospective chart review of cases of cepacia syndrome (CS) in adults with cystic fibrosis (CF)
Objective To evaluate factors influencing the efficacy of provide treatment. Methods Retrospective chart review adult CF patients from July 2006 to December 2013. The patients were divided into two groups: response or non-response to treatment. BMI, severity of genotype, spirometry parameters, performed therapy, white blood cell count at admission ...
M. Usacheva, S. Krasovskiy, E. Amelina
openaire +1 more source
Pediatric Pulmonology, Volume 60, Issue 11, November 2025.
Andreas M. Matthaiou +3 more
wiley +1 more source

